1,186,375 Shares in Stevanato Group S.p.A. $STVN Bought by Ranger Investment Management L.P.

Ranger Investment Management L.P. bought a new stake in Stevanato Group S.p.A. (NYSE:STVN) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,186,375 shares of the company’s stock, valued at approximately $21,438,000. Stevanato Group comprises about 1.4% of Ranger Investment Management L.P.’s portfolio, making the stock its 29th biggest position.

Several other hedge funds have also recently added to or reduced their stakes in STVN. Confluence Investment Management LLC purchased a new position in shares of Stevanato Group during the second quarter valued at about $6,062,000. Conestoga Capital Advisors LLC lifted its holdings in Stevanato Group by 7.6% in the first quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock worth $116,762,000 after buying an additional 602,050 shares during the period. Royal Bank of Canada boosted its position in Stevanato Group by 15.8% during the 1st quarter. Royal Bank of Canada now owns 421,696 shares of the company’s stock valued at $5,798,000 after acquiring an additional 57,536 shares in the last quarter. Kornitzer Capital Management Inc. KS purchased a new position in shares of Stevanato Group during the 1st quarter worth approximately $1,856,000. Finally, Roubaix Capital LLC grew its holdings in shares of Stevanato Group by 96.6% during the 1st quarter. Roubaix Capital LLC now owns 385,316 shares of the company’s stock worth $5,298,000 after acquiring an additional 189,343 shares during the period.

Stevanato Group Stock Performance

Shares of Stevanato Group stock opened at €22.60 on Monday. Stevanato Group S.p.A. has a 1 year low of €12.89 and a 1 year high of €28.00. The firm’s 50-day moving average is €19.48 and its 200 day moving average is €17.27. The stock has a market cap of $6.84 billion, a price-to-earnings ratio of 40.36, a PEG ratio of 1.85 and a beta of 0.77. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.61 and a quick ratio of 1.08.

Stevanato Group (NYSE:STVN) last issued its earnings results on Wednesday, August 5th. The company reported €0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.15 by (€0.01). The firm had revenue of €302.00 million during the quarter. Stevanato Group had a return on equity of 10.43% and a net margin of 10.99%. Sell-side analysts anticipate that Stevanato Group S.p.A. will post 0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

STVN has been the topic of several research reports. TD Cowen upgraded Stevanato Group to a “strong-buy” rating in a research report on Wednesday, June 17th. Weiss Ratings upgraded Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 16th. Finally, Wolfe Research initiated coverage on Stevanato Group in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Buy”.

Insider Buying and Selling

In other news, Director Karen Flynn sold 1,493 shares of the company’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of €17.09, for a total transaction of €25,515.37. Following the transaction, the director directly owned 5,757 shares of the company’s stock, valued at €98,387.13. This represents a 20.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Lago Marco Dal sold 4,209 shares of the stock in a transaction on Friday, August 7th. The shares were sold at an average price of €20.09, for a total value of €84,558.81. Following the sale, the chief financial officer directly owned 81,144 shares in the company, valued at €1,630,182.96. This trade represents a 4.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 14,249 shares of company stock worth $268,346 over the last 90 days.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.